1171926-62-7 Usage
Description
(7-chlorobenzo[b]thiophen-2-yl)methanol is a chemical compound characterized by its molecular formula C9H7ClOS. It is a white to off-white solid that possesses a benzothiophene ring with a chlorine atom and a methanol group attached at specific positions. The unique arrangement of these functional groups endows (7-chlorobenzo[b]thiophen-2-yl)methanol with distinct chemical and physical properties, making it a valuable building block in the synthesis of complex organic molecules and pharmaceuticals.
Uses
Used in Pharmaceutical Industry:
(7-chlorobenzo[b]thiophen-2-yl)methanol is used as a building block for the synthesis of complex organic molecules and pharmaceuticals due to its unique structure and reactivity. Its potential applications in the development of new drugs and agrochemicals make it a promising compound for further research and development in the pharmaceutical sector.
Used in Chemical Industry:
In the chemical industry, (7-chlorobenzo[b]thiophen-2-yl)methanol serves as an important intermediate for the production of various chemical compounds. Its unique functional groups allow for a wide range of chemical reactions, making it a versatile compound for use in the synthesis of specialty chemicals and materials.
Check Digit Verification of cas no
The CAS Registry Mumber 1171926-62-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,7,1,9,2 and 6 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1171926-62:
(9*1)+(8*1)+(7*7)+(6*1)+(5*9)+(4*2)+(3*6)+(2*6)+(1*2)=157
157 % 10 = 7
So 1171926-62-7 is a valid CAS Registry Number.
1171926-62-7Relevant articles and documents
INHIBITORS TARGETING DRUG-RESISTANT INFLUENZA A
-
Paragraph 0416, (2013/06/27)
Provided are compounds according to formula (la) or (lb) as described herein, that are capable of modulating the activity of influenza viruses (e.g., influenza A virus), for example, via interaction with the M2 transmembrane protein, and other similar viroporins. Also provided are methods for treating an influenza A-affected disease state or infection comprising administering a composition comprising one or more compounds according to according to formulas (la') or (lb), as described herein.
